Warburg Pincus is close to acquiring more than 30% of French diagnostics company Sebia, according to a report by Bloomberg citing people familiar with the matter. The deal, which would reportedly value Sebia at approximately €5.5bn, would make Warburg its largest shareholder, and could be reached in the coming days.
Sebia operates in over 120 countries, providing equipment and reagents for the screening and monitoring of various diseases, primarily in oncology.
Private equity firm CVC Capital Partners and Canadian pension fund La Caisse are said to be among the exiting investors. Talks are ongoing and terms could still change.
